// App-Quantinova.ai

4737 : New platinum (Pt)-based anticancer agents, bearing a PtN2SO coordination core, for treating advanced melanoma

Researchers

Presenter

  • Kenneth K.W. To

Principal Investigators

  • Peace Chong

  • Steve C.F. Au-Yeung

Medical Centers

  • The Chinese University of Hong Kong, Hong Kong, Hong Kong

Locations

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • c-Jun N-terminal kinase

  • Proto-oncogene tyrosine-protein kinase ROS

  • Extracellular signal-regulated kinase

Drug/Treatment

  • Oxaliplatin

  • Cisplatin

  • sulfur topical

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved